Carcinogen substrate specificity of human COX-1 and COX-2

Carcinogenesis

Volumn 22, Issue 1, 2001, Pages 5-10

  Wiese, Frederick W ^a,b,c   Thompson, Patricia A ^b,d   Kadlubar, Fred F ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^c Genometrix Inc   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; 2 AMINO 3,8 DIMETHYLIMIDAZO[4,5 F]QUINOXALINE; 4 BIPHENYLAMINE; 4,4' METHYLENEBIS(2 CHLOROANILINE); 7,8 DIHYDROXYBENZO[A]PYRENE 9,10 OXIDE; ARACHIDONIC ACID; AROMATIC AMINE; BENZIDINE; CARCINOGEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DNA; HETEROCYCLIC AMINE; ISOENZYME; PROSTAGLANDIN SYNTHASE; RECOMBINANT ENZYME;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CATALYSIS; CONTROLLED STUDY; COVALENT BOND; DNA BINDING; DOCUMENTATION; ENZYME ASSAY; ENZYME SPECIFICITY; HUMAN; LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 0035142384     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/22.1.5     Document Type: Article

References (49)

1. Prostaglandin synthase 2
2. Prostaglandin endoperoxide synthase: Structure and catalysis
3. Prostaglandin H Synthase
4. Stimulation of prostaglandin E2 production by IL-1α and TGF-α in osteoblastic MC3T3-E1 cells
5. Regulation of cyclooxygenase-2 in aortic smooth muscle cells Arterioscler
6. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue
7. Dihydroxy bile acids activate the transcription of cyclooxygenase-2
8. Benzo[a]pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells
9. Induction of human prostaglandin endoperoxide H synthase mRNA by TCDD
10. COX-2 expression is induced by UVB exposure in human skin: Implications for the development of skin cancer
11. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer
12. Expression of cyclooxygenase-1 and -2 in human colorectal cancer
13. Cyclooxygenase-2 gene expression in human breast cancer
14. Increased expression of cyclooxygenase-2 occurs frequently in human lung cancers, specifically in adenocarcinomas
15. Expression of cyclooxygenase-2 in human lung carcinoma
16. Different substrate utilization between prostaglandin endoperoxide H synthase-1 and -2 in NIH3T3 fibroblasts
17. Fatty acid substrate specificities of human prostaglandin endoperoxide H synthase-1 and -2
18. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2
19. Comparison of hydroperoxide initiator requirements for the cyclooxygenase activities of prostaglandin H synthase-1 and -2
20. Arachidonic acid-dependent peroxidative activation of carcinogenic arylamines by extrahepatic human tissue microsomes
21. Prostaglandin H synthase mediated metabolism and mutagenic activation of IQ
22. Reducing substrate activity of some aromatic amines for prostaglandin H synthase
23. Prostaglandin hydroperoxidase-dependent activation of heterocyclic aromatic amines
24. Mechanism of selective inhibition of human prostaglandin G/H synthase-1 and -2 in intact cells
25. Activation of heterocyclic amines by combinations of prostaglandin H synthase-1 and -2 with N-acetyltransferase 1 and 2
26. Activation of 2-aminofluorene by prostaglandin endoperoxide H synthase-2
27. Carcinogenic aromatic amines and amides
28. Prostaglandin synthase-mediated metabolism of carcinogens and a potential role for peroxyl radicals as reactive intermediates
29. Determinations of serum proteins by means of the Biuret reaction
30. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs
31. Reactivity of benzidine diimine with DNA to form N-(deoxyguanosin-8-yl)-benzidine
32. Occupational exposures of hairdressers and barbers and personal use of hair colourants; some hair dyes, cosmetic colourants, industrial dyestuffs and aromatic amines
33. Methylene-bis-ortho-chloroaniline (MOCA): Evaluation of hazards and exposure control
34. Urinary bladder tumors in dogs from 4,4′-methylene-bis(2-chloroaniline) (MOCA)
35. 32P-Postlabeling analysis of DNA adducts of 4,4′-methylenebis(2-chloroaniline) in target and non-target tissues in the dog and their implications for human risk assessment
36. 32P-postlabeling
37. Cyclooxygenase-2 is expressed in bladder during fetal development and stimulated by outlet obstruction
38. Characterization of benzidine diimine: A product of peroxidase metabolism of benzidine
39. Ram seminal vesicle microsome-catalyzed activation of benzidine and related compounds: Dissociation of mutagenesis from peroxidase-catalyzed formation of DNA-reactive material
40. Mutagenic activation of benzidine requires prior bacterial acetylation and subsequent conversion by prostaglandin H synthase to 4-nitro-4'-(acetylamino) biphenyl
41. Development of an antipeptide antibody that binds to the C-terminal region of human CYP1B1
42. Reduction in formation and growth of 1,2-dimethyl-hydrazine-induced aberrant crypt foci in rat colon by docosahexaenoic acid
43. Effect of docosahexaenoic acid on azoxymethane-induced colon carcinogenesis in rats
44. Inhibitory effect of dietary perilla oil rich in the n-3 polyunsaturated fatty acid α-linolenic acid on colon carcinogenesis in rats
45. Reduction in formation of PhIP-induced aberrant crypt foci in the rat colon by docosahexaenoic acid (DHA)
46. Δ716 knockout mice by inhibition of cyclooxygenase-2 (COX-2)
47. 716 knockout mice
48. 716 knockout mice